CN102671152B - Traditional Chinese medicine compound preparation for treating endometriosis and preparation method of traditional Chinese medicine compound preparation - Google Patents
Traditional Chinese medicine compound preparation for treating endometriosis and preparation method of traditional Chinese medicine compound preparation Download PDFInfo
- Publication number
- CN102671152B CN102671152B CN201110060156.5A CN201110060156A CN102671152B CN 102671152 B CN102671152 B CN 102671152B CN 201110060156 A CN201110060156 A CN 201110060156A CN 102671152 B CN102671152 B CN 102671152B
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- compound preparation
- chinese medicine
- preparation
- treating endometriosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 150000001875 compounds Chemical class 0.000 title claims abstract description 23
- 201000009273 Endometriosis Diseases 0.000 title claims abstract description 19
- 241000545744 Hirudinea Species 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 19
- 244000178320 Vaccaria pyramidata Species 0.000 claims abstract description 14
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims abstract description 13
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 13
- 235000008397 ginger Nutrition 0.000 claims abstract description 13
- 241000005787 Cistanche Species 0.000 claims abstract description 12
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 10
- 239000007787 solid Substances 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 239000006186 oral dosage form Substances 0.000 claims abstract description 6
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 4
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 3
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 3
- 244000273928 Zingiber officinale Species 0.000 claims abstract 4
- 239000002994 raw material Substances 0.000 claims abstract 3
- 238000002156 mixing Methods 0.000 claims description 26
- 229920002472 Starch Polymers 0.000 claims description 21
- 239000008107 starch Substances 0.000 claims description 21
- 235000019698 starch Nutrition 0.000 claims description 21
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000270666 Testudines Species 0.000 claims description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 239000008187 granular material Substances 0.000 claims description 15
- 239000002023 wood Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 244000132619 red sage Species 0.000 claims description 12
- 241000131329 Carabidae Species 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 235000019359 magnesium stearate Nutrition 0.000 claims description 10
- 229940107666 astragalus root Drugs 0.000 claims description 8
- 241000222640 Polyporus Species 0.000 claims description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 6
- 235000006533 astragalus Nutrition 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000008101 lactose Substances 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000005352 clarification Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000012869 ethanol precipitation Methods 0.000 claims description 5
- 239000000469 ethanolic extract Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 241000045403 Astragalus propinquus Species 0.000 claims description 4
- 241001061264 Astragalus Species 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 210000004233 talus Anatomy 0.000 claims description 2
- 229910002012 Aerosil® Inorganic materials 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 230000006907 apoptotic process Effects 0.000 abstract description 4
- 241001482311 Trionychidae Species 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 3
- 230000002611 ovarian Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 240000002373 Ficus pumila Species 0.000 abstract description 2
- 235000006718 Ficus pumila Nutrition 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract description 2
- 101710170789 Protein bax Proteins 0.000 abstract description 2
- 244000143590 Salvia chinensis Species 0.000 abstract description 2
- 235000007154 Salvia chinensis Nutrition 0.000 abstract description 2
- 208000031513 cyst Diseases 0.000 abstract description 2
- 210000004696 endometrium Anatomy 0.000 abstract description 2
- 108091007065 BIRCs Proteins 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 abstract 1
- 241001427555 Polyphaga <Blattaria> Species 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- 229940032147 starch Drugs 0.000 description 15
- 239000000843 powder Substances 0.000 description 13
- 241000234314 Zingiber Species 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 235000008429 bread Nutrition 0.000 description 6
- 244000197580 Poria cocos Species 0.000 description 4
- 235000008599 Poria cocos Nutrition 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229940080313 sodium starch Drugs 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 3
- POZRVZJJTULAOH-LHZXLZLDSA-N danazol Chemical compound C1[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=CC2=C1C=NO2 POZRVZJJTULAOH-LHZXLZLDSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
- 241000336291 Cistanche deserticola Species 0.000 description 2
- 240000003421 Dianthus chinensis Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 241000258623 Whitmania pigra Species 0.000 description 2
- 229960000766 danazol Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 241000243818 Annelida Species 0.000 description 1
- 241000336315 Cistanche salsa Species 0.000 description 1
- 241000963421 Curcuma kwangsiensis Species 0.000 description 1
- 240000005629 Curcuma phaeocaulis Species 0.000 description 1
- 235000003391 Curcuma phaeocaulis Nutrition 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241001489978 Eupolyphaga Species 0.000 description 1
- 241001489980 Eupolyphaga sinensis Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- 235000004877 Vaccaria hispanica subsp hispanica Nutrition 0.000 description 1
- 241000869047 Winterella aurantiaca Species 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 229960003248 mifepristone Drugs 0.000 description 1
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicine and relates to a traditional Chinese medicine compound preparation for treating endometriosis and a preparation method of the traditional Chinese medicine compound preparation. According to the traditional Chinese medicine compound preparation, medicine auxiliary materials and extracts of raw material medicine such as astragali radix, cistanche, scabrousstem greenbrier rhizome, salvia chinensis, climbing fig receptacle, cowherb seed, curcuma zedoary, baked ginger, soft-shelled turtle, Chinese polyphaga and leech are prepared into the traditional Chinese medicine compound preparation for treating endometriosis and solid or liquid oral dosage forms of the compound preparation. Animal experiment results show that the compound preparation can obviously reduce the inhibitor of apoptosis protein bc1-2 content and can improve the apoptosis promoting protein bax content, so the bc1-2/bax ratio is reduced, and the ectopic endometrium apoptosis is promoted. Clinical experiment results show that the compound preparation has the effect of shortening the ovarian endometrioid cysts and can be used for treating the endometriosis.
Description
Technical Field
The invention belongs to the field of traditional Chinese medicines, and relates to a traditional Chinese medicine compound preparation for treating endometriosis and a preparation method thereof.
Background
The prior art discloses: when endometrial tissue with growth functions appears in other parts of the body except for the uterine cavity tunica mucosa, endometriosis (EMs, for short, endometriosis) is called, wherein the ovarian invasion is most common, also called as endometrioid cyst, and accounts for about 80 percent, and the symptoms mainly include gradually aggravated dysmenorrhea, persistent lower abdominal pain, menstrual disorder, infertility and the like, and are frequently-occurring diseases and difficult diseases in the gynecological field. The pathological features of the endogenous diseases are that the ectopic intima is periodically bleeded, accompanied by the proliferation and adhesion of surrounding fibrous tissues, and purple blue solid nodules and masses are formed in the diseased region. The pathogenesis of endometriosis is not well defined, and several theories exist, such as: the theory of endometrium implantation, the theory of coelomic epithelialization, the theory of embryo remaining and the theory of lymphatic vessel metastasis, the theory of induction, immune factors, endocrine factors, etc., and the recent theory of in-situ intima determination and stem cell origin, all fail to fully explain the clinical classification of various types of EMs. Therefore, the method for treating endometriosis has certain limitations and data statistics, and hormone drugs or surgical treatment relapse within 1 year and the 5-year relapse rate is over 40 percent, which causes great physical and psychological pain and economic burden to patients, so the method has important social and economic significance for actively preventing and treating endometriosis.
However, there is no ideal therapeutic drug with specific effect and little side effect in clinic. Currently, western medicines mainly comprise hormone medicines such as GnRHA medicines, danazol, namedone, tamoxifen, mifepristone and the like, although symptoms can be temporarily relieved, the western medicines cannot radically cure the symptoms, and the practical problems of high recurrence rate after stopping the medicine, large side effect, high cost and the like of the hormone medicines cause difficulty in acceptance of patients.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a traditional Chinese medicine compound preparation for treating endometriosis and a preparation method thereof. The traditional Chinese medicine compound preparation has good curative effect on endometriosis.
The invention also aims to provide a preparation method of the traditional Chinese medicine compound preparation for treating endometriosis.
The invention adopts the extracts of the following traditional Chinese medicinal materials to prepare the compound preparation for treating endometriosis.
The compound preparation comprises the following raw medicinal materials: raw astragalus root, broomrape, turtle shell, Siberian cocklebur, Chinese sage herb, wood steamed bread, wood louse, leech, seed of cowherb, zedoary and baked ginger.
The weight/weight ratio of the raw medicinal materials is as follows: 10-30% of raw astragalus membranaceus, 3-15% of cistanche, 3-15% of roasted turtle shell, 3-15% of polyporus ferroportinus, 3-15% of Chinese sage herb, 3-15% of wood steamed bun, 3-15% of ground beetle, 1-10% of leech, 3-15% of cowherb seed, 8-25% of curcuma zedoary and 1-10% of roasted ginger.
The invention adopts the extracts of the traditional Chinese medicinal materials and adds medicinal auxiliary materials to prepare oral solid preparations such as granules, tablets, capsules, effervescent tablets and the like.
The auxiliary materials used for forming the preparation comprise dextrin, lactose, sodium bicarbonate, citric acid, hydroxymethyl starch sodium, superfine silica gel powder, starch, soluble starch and magnesium stearate which are medicinal specification auxiliary materials.
The quality of the traditional Chinese medicine materials (except that the turtle shell, the ground beetle, the leech and the baked ginger are in accordance with the processing specification of the Shanghai city medicines (1994 version)) adopted by the invention is in accordance with the relevant regulations under the corresponding medicinal material item of the first part of the Chinese pharmacopoeia in 2005. Wherein,
the radix astragali is root of Astragalus membranaceus (Fisch.) Bge. belonging to Leguminosae perennial herbaceous plant, Astragalus membranaceus (Fisch.) Bge.
Cistanche deserticola is succulent stem with scaly leaves of Cistanche deserticola Y.C.Ma which is a year-old parasitic herb of Orobanchaceae.
The carapax Trionycis preparata is the dorsal scale of Trionyx sinensis Wiegmann of Trionychidae.
The rhizoma Smilacis Glabrae is rhizome of Smilax china L.
The herba Salviae chinensis is whole plant of Salvia chinensis Benth.
The wood steamed bread is stem and leaf of Ficus pumila Linn of Moraceae.
The Eupolyphaga Seu Steleophaga is female dry body of Eupolyphagasinensis Walker or Steleophaga plancyi (Boleny) belonging to family Trionychidae.
The Hirudo is the whole body of Whitman, Whitmania pigra Whitman, Whitman or Whitman W.aurantiaca Whitman of Whitmania pigra of Annelida.
Vaccaria segetalis (Neck.) Garke mature seed of annual or perennial herb of Dianthus vaccia of Dianthus family.
The Curcumae rhizoma is rhizome of Curcuma zedoaria Curcuma phaeocaulis Val, Curcuma kwangsiensis C.kwangsiensis S.Lee et C.F.Liang or Curcuma wenyujin C.wenyujin Y.H.Chen et C.Ling.
The baked ginger is a dried old root processed product of ginger.
The invention provides a preparation method of the traditional Chinese medicine compound preparation.
The invention is prepared by the following method:
weighing eight medicines of raw astragalus, cistanche, Indian bread with iron thorns, Chinese sage herb, wood steamed bread, cowherb seed and rhizoma zedoariae baked ginger according to a formula, and adding ethanol for extraction for 3 times, wherein the extraction lasts for 1-2 hours each time; decocting and extracting roasted turtle shells, ground beetles and leeches, namely soaking the roasted turtle shells, the ground beetles and the leeches in water for 1 hour, adding 8-10 times of the water, extracting for three times, concentrating a water extracting solution to the relative density of 1.08-1.12, and then carrying out purification treatment, wherein the purification method can be an ethanol precipitation method, a centrifugation method or a chitosan clarification method; mixing the above ethanol extract and water extract, mixing, adding adjuvant, and making into solid or liquid oral dosage form by the following method: mixing the above extracts, adding dextrin, spray drying to obtain fine powder, and granulating by dry method to obtain granule; or adding sodium hydroxymethyl starch, silica gel micropowder, soluble starch, lactose, and magnesium stearate, mixing, and making into granule with 95% ethanol; drying and tabletting; adding appropriate amount of silica gel micropowder, mixing, and making into capsule; or adding citric acid and starch into part of the fine powder to make granule; adding sodium bicarbonate and starch into the rest fine powder, and granulating. Adding magnesium stearate into the two granules, mixing, and tabletting.
The results of animal experiments show that the compound preparation: can obviously reduce the content of the apoptosis inhibiting protein bcl-2 and increase the content of the apoptosis promoting protein bax, thereby reducing the ratio of bcl-2/bax and promoting the ectopic intimal apoptosis, and the effect is better than that of a contrast medicament (danazol). Table 1 shows the changes in the ectopic intima tissue bcl-2/bax of each group of EMs model rats
TABLE 1
Note: p < 0.01, P < 0.05, vs model group; # P < 0.01, vs danazol group.
The clinical test result shows that the compound preparation comprises the following components: can reduce endometrioid cyst of ovary, and has therapeutic effect on contrast drug such as Daphne (GnRHA). TABLE 2 Change in maximum radial line before and after endometrioid ovarian treatment
TABLE 2
Note: p < 0.05, vs pre-treatment.
Detailed Description
Example 1
Taking the traditional Chinese medicinal materials in a formula amount, wherein the weight/weight ratio of the traditional Chinese medicinal materials is as follows: 15% of raw astragalus root, 10% of cistanche, 10% of polyporus sibiricus, 10% of Chinese sage herb, 10% of wood steamed bun, 10% of cowherb seed, 10% of curcuma zedoary, 5% of baked ginger, 10% of baked turtle shell, 5% of ground beetle and 5% of leech; wherein the eight medicines of raw astragalus root, desertliving cistanche, Indian bread with iron thorn, Chinese sage herb, wood steamed bread, cowherb seed and rhizoma zedoariae are extracted by adding ethanol for 3 times, and each extraction is carried out for 2 hours; decocting and extracting roasted turtle shells, ground beetles and leeches, namely soaking the roasted turtle shells, the ground beetles and the leeches in water for 1 hour, adding 10 times of water, extracting for three times, concentrating a water extracting solution to the relative density of 1.08-1.12, and purifying by adopting an ethanol precipitation method, a centrifugation method or a chitosan clarification method; mixing the above ethanol extract and water extract, mixing, drying, adding adjuvant, and making into solid or liquid oral dosage form.
The preparation formulation is prepared by adopting the following preparation method: mixing the extracts, adding dextrin, spray drying to obtain fine powder, and granulating by dry method to obtain granule; or adding sodium hydroxymethyl starch, silica gel micropowder, soluble starch, lactose, and magnesium stearate, mixing, and making into granule or tablet with 95% ethanol; or adding appropriate amount of silica gel micropowder, mixing, and making into capsule; or adding citric acid and starch into part of the fine powder, granulating, adding sodium bicarbonate and starch into the rest fine powder, granulating, adding magnesium stearate into the two granules, mixing, and tabletting.
Example 2
Taking the traditional Chinese medicinal materials in a formula amount, wherein the weight/weight ratio of the traditional Chinese medicinal materials is as follows: 15% of raw astragalus root, 10% of cistanche, 10% of polyporus sibiricus, 10% of Chinese sage herb, 10% of wood steamed bun, 10% of cowherb seed, 10% of curcuma zedoary, 5% of baked ginger, 10% of baked turtle shell, 5% of ground beetle and 5% of leech;
wherein the eight medicines of raw astragalus root, desertliving cistanche, Indian bread with iron thorn, Chinese sage herb, wood steamed bread, cowherb seed and rhizoma zedoariae are extracted by adding ethanol for 3 times, and each extraction time is 1.5 hours; decocting and extracting roasted turtle shells, ground beeltles and leeches, namely soaking the roasted turtle shells, the ground beeltles and the leeches in water for 1 hour, adding 8 times of water, extracting for three times, concentrating a water extracting solution to the relative density of 1.08-1.12, and purifying by adopting an ethanol precipitation method, a centrifugation method or a chitosan clarification method; mixing the above ethanol extract and water extract, mixing, drying, adding adjuvant, and making into solid or liquid oral dosage form.
The preparation formulation is prepared by adopting the following preparation method: mixing the extracts, adding dextrin, spray drying to obtain fine powder, and granulating by dry method to obtain granule; or adding sodium hydroxymethyl starch, silica gel micropowder, soluble starch, lactose, and magnesium stearate, mixing, and making into granule or tablet with 95% ethanol; or adding appropriate amount of silica gel micropowder, mixing, and making into capsule; or adding citric acid and starch into part of the fine powder, granulating, adding sodium bicarbonate and starch into the rest fine powder, granulating, adding magnesium stearate into the two granules, mixing, and tabletting.
Example 3
Taking the traditional Chinese medicinal materials in a formula amount, wherein the weight/weight ratio of the traditional Chinese medicinal materials is as follows: 15% of raw astragalus root, 10% of cistanche, 10% of polyporus sibiricus, 10% of Chinese sage herb, 10% of wood steamed bun, 10% of cowherb seed, 10% of curcuma zedoary, 5% of baked ginger, 10% of baked turtle shell, 5% of ground beetle and 5% of leech; wherein the eight medicines of raw astragalus root, desertliving cistanche, Indian bread with iron thorn, Chinese sage herb, wood steamed bread, cowherb seed and rhizoma zedoariae are extracted by adding ethanol for 3 times, and each extraction is carried out for 1 hour; decocting and extracting roasted turtle shells, ground beeltles and leeches, namely soaking the roasted turtle shells, the ground beeltles and the leeches in water for 2 hours, adding 10 times of water, extracting for three times, concentrating a water extracting solution to the relative density of 1.08-1.12, and purifying by adopting an ethanol precipitation method, a centrifugation method or a chitosan clarification method; mixing the above ethanol extract and water extract, mixing, drying, adding adjuvant, and making into solid or liquid oral dosage form.
The preparation formulation is prepared by adopting the following preparation method: mixing the extracts, adding dextrin, spray drying to obtain fine powder, and granulating by dry method to obtain granule; or adding sodium hydroxymethyl starch, silica gel micropowder, soluble starch, lactose, and magnesium stearate, mixing, and making into granule or tablet with 95% ethanol; or adding appropriate amount of silica gel micropowder, mixing, and making into capsule; or adding citric acid and starch into part of the fine powder, granulating, adding sodium bicarbonate and starch into the rest fine powder, granulating, adding magnesium stearate into the two granules, mixing, and tabletting.
Claims (4)
1. A traditional Chinese medicine compound preparation for treating endometriosis is characterized by being prepared from the following extracts of raw material medicines in weight/weight ratio and medicinal auxiliary materials: 10-30% of raw astragalus membranaceus, 3-15% of cistanche, 3-15% of roasted turtle shell, 3-15% of polyporus ferroportinus, 3-15% of Chinese sage herb, 3-15% of wood steamed bun, 3-15% of ground beetle, 1-10% of leech, 3-15% of cowherb seed, 8-25% of curcuma zedoary and 1-10% of baked ginger;
is prepared by the following method: taking eight Chinese medicinal materials of raw astragalus, cistanche, polyporus iron-spine, Chinese sage herb, wood steamed bun, cowherb seed, zedoary and baked ginger according to a formula amount, adding ethanol for extraction for 3 times, extracting for 1.5 hours each time, decocting and extracting roasted turtle shell, ground beeltle and leech, namely soaking the roasted turtle shell, the ground beeltle and the leech in water for 1 hour, adding 8 times of water, extracting for three times, concentrating a water extracting solution to a relative density of 1.08-1.12, and purifying by adopting an ethanol precipitation method, a centrifugation method or a chitosan clarification method; mixing the above ethanol extract and water extract, mixing, drying, adding adjuvant, and making into solid or liquid oral dosage form.
2. The compound traditional Chinese medicine preparation for treating endometriosis according to claim 1, wherein the weight/weight ratio of the raw material medicines is as follows: 15% of raw astragalus root, 10% of cistanche, 10% of polyporus sibiricus, 10% of Chinese sage herb, 10% of wood steamed bun, 10% of cowherb seed, 10% of curcuma zedoary, 5% of baked ginger, 10% of baked turtle shell, 5% of ground beetle and 5% of leech.
3. The compound Chinese medicinal preparation for treating endometriosis according to claim 1, wherein the dosage form is granules, tablets or capsules.
4. The compound Chinese medicinal preparation for treating endometriosis according to claim 1, wherein the auxiliary materials are selected from dextrin, lactose, sodium bicarbonate, citric acid, sodium hydroxymethyl starch, aerosil, starch or magnesium stearate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110060156.5A CN102671152B (en) | 2011-03-11 | 2011-03-11 | Traditional Chinese medicine compound preparation for treating endometriosis and preparation method of traditional Chinese medicine compound preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110060156.5A CN102671152B (en) | 2011-03-11 | 2011-03-11 | Traditional Chinese medicine compound preparation for treating endometriosis and preparation method of traditional Chinese medicine compound preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102671152A CN102671152A (en) | 2012-09-19 |
CN102671152B true CN102671152B (en) | 2014-11-26 |
Family
ID=46804135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110060156.5A Expired - Fee Related CN102671152B (en) | 2011-03-11 | 2011-03-11 | Traditional Chinese medicine compound preparation for treating endometriosis and preparation method of traditional Chinese medicine compound preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102671152B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103099901B (en) * | 2013-01-26 | 2014-07-30 | 张红 | Traditional Chinese medicine enema for treating endometriosis |
-
2011
- 2011-03-11 CN CN201110060156.5A patent/CN102671152B/en not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
《陈熠运用百通消瘤法治疗妇科良性肿瘤经验》;石书芳等;《中成药》;20081231(第3期);24-26 * |
石书芳等.《陈熠运用百通消瘤法治疗妇科良性肿瘤经验》.《中成药》.2008,(第3期), * |
Also Published As
Publication number | Publication date |
---|---|
CN102671152A (en) | 2012-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105663607B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN104491801A (en) | Traditional Chinese medicine preparation for treating acute or chronic gastritis and preparation method thereof | |
CN1806840B (en) | Chinese medicinal compound preparation and its preparing process | |
CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
CN104491802A (en) | Application of traditional Chinese medicine preparation in preparation of medicine for treating acute or chronic gastritis | |
CN104027684A (en) | Traditional Chinese medicinal composition for treating gout and preparation method thereof | |
CN104338031A (en) | Leukocyte-increasing traditional Chinese medicine decoction piece combined preparation as well as preparation method and combined package thereof | |
KR101600751B1 (en) | Method of preparing oriental medicine composition containing extract of deer antlers for treating infertility in women | |
CN103611021B (en) | Be used for the treatment of medicine of Vesica sus domestica inflammation and preparation method thereof | |
CN103341092A (en) | Preparation method of powder for treating atrophic vaginitis | |
CN101138597A (en) | Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same | |
CN103652450B (en) | Pig feed and preparation method thereof | |
CN103301353B (en) | Pharmaceutical composition for treating atrophic vaginitis | |
CN102671152B (en) | Traditional Chinese medicine compound preparation for treating endometriosis and preparation method of traditional Chinese medicine compound preparation | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN115414441A (en) | Traditional Chinese medicine composition with effects of nourishing blood, regulating menstruation, removing blood stasis and removing ecchymoses as well as preparation method and application thereof | |
CN112274619B (en) | Composition for relieving dysmenorrhea and application of composition in preparation of medicines, health-care products or foods | |
CN104306662A (en) | Traditional Chinese medicine composition for treating neurasthenia and preparation method thereof | |
CN103285284A (en) | Medical composition for treating senile vaginitis | |
CN111481614A (en) | Application of Wubi yam pills in preparation of medicine for treating perimenopausal syndrome | |
CN105362630A (en) | Climacteric syndrome treatment pharmaceutical composition and preparation method thereof | |
CN104983899A (en) | Traditional Chinese medicine composition for treating female deficiency of qi and blood | |
CN104398662A (en) | Traditional Chinese medicine preparation treating femur head necrosis and preparation technology thereof | |
CN103520354A (en) | Traditional Chinese medicine for treatment of blood-insufficiency type mammary gland hyperplasia and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141126 |